📌 Key Takeaways
- Topic: Silica Gel Manufacturer: Product Types, Quality Standards and Selection Guide
- Keywords: silica for coatings
- Published: 2026-11-20 10:34:48
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Supplier Thailand: Market Overview and Sourcing Options
- Fumed Silica CAS 112945-52-5: Identification, Properties and Safety Data
- U.S. Silica: Company Overview, Products and Markets Served
- Silica for Rheology Control: How to Select the Right Silica and Dosage
- Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325
- Tosoh Silica: Product Range, Applications and Key Grades
Silica for Powder Coatings: Flow Aid, Matting and Anti-Caking Functions
What is silica (SiO₂)?
electronic grade silica This review provides an overview of the development of MSNs in the biomedical field, highlighting some key research advances, briefly summarizing the types of MSNs developed by different research groups (M41S-series, SBA-series, FDU-series, KIT-series, etc.). Moreover, in view of the high versatility of MSNs-based nanocomposites for diagnostic and therapeutic applications, the current MSNs-based architectures and the types of nanocomposites by active elements are summarized. Subsequently, the purpose of surface functionalization of MSNs is examined. Further, we comprehensively review the biomedical applications of MSNs, among them biosensing, bioimaging, targeted disease therapy, and tissue engineering, etc. In particular, targeted therapeutic modalities based on various strategies are meticulously discussed. Finally, the current status of MSNs in clinical trials is presented. It is believed that this review will deliver a thorough understanding of MSNs involved in the development history, design, functionalization, and biomedical applications. In spite of numerous breakthroughs, the current challenges in MSNs research include three chief facets: systematic toxicity study, construction of straightforward but efficient MSNs-based nanoplatforms, and in-depth insight into the in vivo action mechanism.
What is the difference between fumed silica and precipitated silica?
silica for electronic encapsulation
What drives silica raw material prices?
top fumed silica manufacturers Germain, M. et al. Delivering the power of nanomedicine to patients today. J. Control. Release 326, 164-171 (2020). Article CAS PubMed Central PubMed Google Scholar
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.